Global Fermenters Market to Hit USD 4.8 Billion by 2035 | CAGR 8.51%
08 Aug 2025 | Report ID: MI3290 | Industry: Novel Technology | Pages: 218 | Forecast Year: 2025-2035

Read more about this report- Global Fermenters Market to Hit USD 4.8 Billion by 2035 | CAGR 8.51%
The Fermenters Market accounted for USD 1.97 billion in 2024 and is expected to reach USD 4.8 billion by 2035, growing at a CAGR of around 8.51% between 2025 and 2035.
The growing market demand in pharmaceuticals and the food industry for biologics and products based on cells is one of the key growth drivers. But the cost of maintenance and the initial cost of using fermenters impede smaller manufacturers. Significant potential is the use of AI and IoT in fermenter systems, boosting performance and monitoring the process in real-time.
The product types used to segment the market are submerged, solid state, application, batch, fed-batch, continuous, industrial, research institutes, and others. The major one of them is the pharmaceutical application segment, which is being driven by the growing production of biosimilars along with the surging investments in biologic production.
The areas of application are the application in food and beverage fermentation, pharmaceutical production, biofuel production, and research and development. The pharmaceutical sector is experiencing fast-paced technological integration, such as automation and single-use fermenters, which offer scalability of production and meet GMP requirements. The prominent trend is the Production Linked Incentive (PLI) scheme that unfolds in India and encourages the production of pharmaceutical equipment locally, stimulating market access.
The market, using a geographical basis, is in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In China, the market demand and adoption are largely influenced by government investments in biotech research and the explosive procurement of biopharma manufacturing sites.
Noticeable organisational customers affecting the market are Sartorius AG, Thermo Fisher Scientific Inc., Eppendorf AG, Merck KGaA, and a fictional company, BioFerma Solutions. These organisations are taking advantage of modular designs and intelligent fermentation management, and partnering with research institutions, to increase the service offerings and better position the product.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.